Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingde Ma

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Inequalities and Applications|August 22, 2017
A new bound on the block restricted isometry constant in compressed sensingYi Gao, Mingde Ma
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 2017
Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathwayZhenyu Zhou, Yang Liu, Mingde Ma, et al.
Oncotargets and Therapy|December 11, 2019
LINC00096 Promotes the Proliferation and Invasion by Sponging miR-383-5p and Regulating RBM3 Expression in Triple-Negative Breast CancerYanyan Tian, Shuguan Xia, Mingde Ma, et al.
Medicine|December 5, 2023
Peripheral blood inflammatory indexes in breast cancer: A reviewJiaqiang Xie, Zhenxi Guo, Yijing Zhu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 2, 2023
JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesisYonggang Zuo, Mingde Ma, Yuqing Wen, et al.
RSC Advances|May 13, 2022
Retracted Article: Down-regulation of Rab10 inhibits hypoxia-induced invasion and EMT in thyroid cancer cells by targeting HIF-1α through the PI3K/Akt pathwayZhenyu Zhou, Yang Liu, Zhuang Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 17, 2017
Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancerYonggang Zuo, Yue Li, Zhenyu Zhou, et al.
Biofactors (Oxford, England)|May 18, 2021
The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancerYonggang Zuo, Changping Qu, Yanyan Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2025
Application of Neoadjuvant Docetaxel Plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II TrialDechuang Jiao, Jianghua Qiao, Xianfu Sun, et al.
Medcomm|December 11, 2023
A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancerQiyun Shi, Xiaowei Qi, Peng Tang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Inequalities and Applications|August 22, 2017
A new bound on the block restricted isometry constant in compressed sensingYi Gao, Mingde Ma
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 2, 2017
Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathwayZhenyu Zhou, Yang Liu, Mingde Ma, et al.
Oncotargets and Therapy|December 11, 2019
LINC00096 Promotes the Proliferation and Invasion by Sponging miR-383-5p and Regulating RBM3 Expression in Triple-Negative Breast CancerYanyan Tian, Shuguan Xia, Mingde Ma, et al.
Medicine|December 5, 2023
Peripheral blood inflammatory indexes in breast cancer: A reviewJiaqiang Xie, Zhenxi Guo, Yijing Zhu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 2, 2023
JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesisYonggang Zuo, Mingde Ma, Yuqing Wen, et al.
RSC Advances|May 13, 2022
Retracted Article: Down-regulation of Rab10 inhibits hypoxia-induced invasion and EMT in thyroid cancer cells by targeting HIF-1α through the PI3K/Akt pathwayZhenyu Zhou, Yang Liu, Zhuang Hu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 17, 2017
Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancerYonggang Zuo, Yue Li, Zhenyu Zhou, et al.
Biofactors (Oxford, England)|May 18, 2021
The HIF-1/SNHG1/miR-199a-3p/TFAM axis explains tumor angiogenesis and metastasis under hypoxic conditions in breast cancerYonggang Zuo, Changping Qu, Yanyan Tian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2025
Application of Neoadjuvant Docetaxel Plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II TrialDechuang Jiao, Jianghua Qiao, Xianfu Sun, et al.
Medcomm|December 11, 2023
A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancerQiyun Shi, Xiaowei Qi, Peng Tang, et al.
Pageof 1